Scott Stout has been recognized as one of the top healthcare innovators of 2021.  While working as a professional investor in high-finance, Scott identified a large gap in the clinical trial marketplace and seized the opportunity to build a team of healthcare, high tech, and venture capitalists to turn his concept of expanding clinical trials, “Beyond Clinical Trial Sites,” into a reality.  Prior to founding MedVector, Scott worked with notable companies such as Morgan Stanley and Wells Fargo Private Bank.  His entrepreneurial spirit has driven him to help numerous start-ups develop their market-fit, revenue models, capital raises, and go-to-market strategies.